Politics

Ways for scientists to deal with Trump election

President-Trump-Thumbs-up-for-science-e1478810820633

Since Donald Trump was elected our new president the scientific community has tried to adjust to this new reality or at least absorb the shock that many felt. Responses from scientists range from “not my president” to “maybe it won’t be so bad”. Mostly it seems people are stressed about an uncertain future for science

Ways for scientists to deal with Trump election Read More »

Ten patient groups oppose REGROW Act that would gut stem cell oversight

michael-j.-fox-foundation

The REGROW Act would drastically weaken FDA regulation of experimental stem cell therapies. I’ve criticized it in numerous posts (see those here) for its radical ideas that would put patients and the stem cell field at risk. I’m not the only one concerned about it as both ARM and ISSCR oppose it too. Now 10 top patient advocacy

Ten patient groups oppose REGROW Act that would gut stem cell oversight Read More »

Cons Outweigh Potential Pros to BPC Plan on Stem Cells & FDA

BPC-report-stem-cels

There is considerable interest in FDA regulatory reform here in the U.S. for stem cell therapies. The goal is to get new treatments to patients faster, but is there a way to do that without sacrificing proven safety and efficacy? You need convincing data on both safety and efficacy or speed becomes dangerous. Bipartisan Policy Center

Cons Outweigh Potential Pros to BPC Plan on Stem Cells & FDA Read More »

White House supports moratorium on heritable human CRISPR

John_Holdren

The Obama Administration today weighed in on human germline genetic modification such as via CRISPR via a note from John Holdren, Assistant to the President for Science and Technology, and Director of the White House Office of Science and Technology Policy. The White House indicated support for the National Academy of Sciences (NAS) and the National Academy

White House supports moratorium on heritable human CRISPR Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.